共 50 条
- [31] Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failureBLOOD ADVANCES, 2020, 4 (13) : 2866 - 2870Ball, Brian J.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USAFamulare, Christopher A.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Ctr Hematol Malignancies, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USAStein, Eytan M.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USATallman, Martin S.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USADerkach, Andriy论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USARoshal, Mikhail论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USAGill, Saar, I论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USAManning, Benjamin M.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USAKoprivnikar, Jamie论文数: 0 引用数: 0 h-index: 0机构: Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Div Leukemia, Hackensack, NJ USA Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USAMcCloskey, James论文数: 0 引用数: 0 h-index: 0机构: Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Div Leukemia, Hackensack, NJ USA Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USATesti, Rebecca论文数: 0 引用数: 0 h-index: 0机构: Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Div Leukemia, Hackensack, NJ USA Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USAPrebet, Thomas论文数: 0 引用数: 0 h-index: 0机构: Yale New Haven Med Ctr, Smilow Canc Ctr, Div Hematol Oncol, New Haven, CT 06504 USA Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USAAl Ali, Najla H.论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USAPadron, Eric论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USASallman, David A.论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USAKomrokji, Rami S.论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USAGoldberg, Aaron D.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USA
- [32] RIGOSERTIB IN COMBINATION WITH AZACITIDINE MODULATES EPIGENETIC PATHWAYS AND CAN OVERCOME CLINICAL RESISTANCE TO HYPOMETHYLATING AGENTS IN MYELODYSPLASTIC SYNDROMES (MDS)LEUKEMIA RESEARCH, 2017, 55 : S121 - S121Chaurasia, P.论文数: 0 引用数: 0 h-index: 0机构: Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USAIsoda, F.论文数: 0 引用数: 0 h-index: 0机构: Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USANavada, S.论文数: 0 引用数: 0 h-index: 0机构: Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USAOdchimar-Reissig, R.论文数: 0 引用数: 0 h-index: 0机构: Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USADemakos, E. P.论文数: 0 引用数: 0 h-index: 0机构: Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USAReddy, E. P.论文数: 0 引用数: 0 h-index: 0机构: Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USASilverman, L. R.论文数: 0 引用数: 0 h-index: 0机构: Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA
- [33] Predictors Of Response To Rigosertib In Patients With a Myelodysplastic Syndrome (MDS) Or Acute Myeloid Leukemia (AML) Relapsing After Or Refractory To Hypomethylating AgentsBLOOD, 2013, 122 (21)Navada, Shyamala C.论文数: 0 引用数: 0 h-index: 0Odchimar-Reissig, Rosalie论文数: 0 引用数: 0 h-index: 0Reddy, E. Premkumar论文数: 0 引用数: 0 h-index: 0Demakos, Erin P.论文数: 0 引用数: 0 h-index: 0Holland, James F.论文数: 0 引用数: 0 h-index: 0Wilhelm, Francois论文数: 0 引用数: 0 h-index: 0Silverman, Lewis R.论文数: 0 引用数: 0 h-index: 0
- [34] Impact Of The Achievement Of a Complete Cytogenetic Response (CCyR) On Outcome In Patients (pts) With Myelodysplastic Syndromes (MDS) Treated With Hypomethylating Agents (HMA)BLOOD, 2013, 122 (21)Jabbour, Elias论文数: 0 引用数: 0 h-index: 0Kantarjian, Hagop M.论文数: 0 引用数: 0 h-index: 0Qiao, Wei论文数: 0 引用数: 0 h-index: 0Strati, Paolo论文数: 0 引用数: 0 h-index: 0Khan, Navira F.论文数: 0 引用数: 0 h-index: 0Cortes, Jorge E.论文数: 0 引用数: 0 h-index: 0Hoehn, Daniela论文数: 0 引用数: 0 h-index: 0Hu, Jianhua论文数: 0 引用数: 0 h-index: 0Obrien, Susan论文数: 0 引用数: 0 h-index: 0Bryan, Jeffrey论文数: 0 引用数: 0 h-index: 0Prescott, Hillary论文数: 0 引用数: 0 h-index: 0DiNardo, Courtney D.论文数: 0 引用数: 0 h-index: 0Daver, Naval论文数: 0 引用数: 0 h-index: 0Kadia, Tapan M.论文数: 0 引用数: 0 h-index: 0Garcia-Manero, Guillermo论文数: 0 引用数: 0 h-index: 0
- [35] A Randomized Phase II Study of Low-Dose Decitabine Versus Azacitidine in Patients with Low- or Intermediate-1-Risk Myelodysplastic Syndromes: A Report on Behalf of the MDS Clinical Research ConsortiumBLOOD, 2016, 128 (22)Jabbour, Elias J.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAShort, Nicholas J.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAHuang, Xuelin论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Biostatist, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAMaiti, Abhishek论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAKadia, Tapan M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USADaver, Naval论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USABorthakur, Gautam论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USADiNardo, Courtney D.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAPemmaraju, Naveen论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USASasaki, Koji论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAEstrov, Zeev论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAVerstovsek, Srdan论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USARavandi, Farhad论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAAlvarado, Yesid论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USASekeres, Mikkael A.论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin, Taussig Canc Inst, Leukemia Program, Cleveland, OH USA Cleveland Clin, Dept Hematol & Med Oncol, Leukemia Program, Cleveland, OH USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAKomrokji, Rami S.论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr Res Inst, Dept Malignant Hematol, Tampa, FL USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USASteensma, David P.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USADeZern, Amy E.论文数: 0 引用数: 0 h-index: 0机构: Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Baltimore, MD USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USARoboz, Gail J.论文数: 0 引用数: 0 h-index: 0机构: Weill Cornell Med, Div Hematol & Oncol, New York, NY USA New York Presbyterian Hosp, New York, NY USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAMiller, Darla论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USADong, Xiao论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAKantarjian, Hagop M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USAGarcia-Manero, Guillermo论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
- [36] MUTATIONAL PROFILE AND KARYOTYPIC ABNORMALITIES OF CLINICAL TRIAL PATIENTS WITH HIGHER-RISK MDS FOLLOWING FAILURE OF HYPOMETHYLATING AGENTS (HMAS): IMPACT ON RESPONSE TO RIGOSERTIB THERAPYLEUKEMIA RESEARCH, 2015, 39 : S57 - S57Mufti, G. J.论文数: 0 引用数: 0 h-index: 0机构: Kings Coll Hosp London, Dept Haematol Med, London, England Kings Coll Hosp London, Dept Haematol Med, London, EnglandBest, S.论文数: 0 引用数: 0 h-index: 0机构: Kings Coll Hosp London, Dept Haematol Med, London, England Kings Coll Hosp London, Dept Haematol Med, London, EnglandLea, N.论文数: 0 引用数: 0 h-index: 0机构: Kings Coll Hosp London, Dept Haematol Med, London, England Kings Coll Hosp London, Dept Haematol Med, London, EnglandHellstrom-Lindberg, E.论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp, Dept Med, Stockholm, Sweden Kings Coll Hosp London, Dept Haematol Med, London, EnglandSilverman, L. R.论文数: 0 引用数: 0 h-index: 0机构: Icahn Sch Med Mt Sinai, Div Hematol Oncol, New York, NY 10029 USA Kings Coll Hosp London, Dept Haematol Med, London, EnglandGarcia-Manero, G.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Med, Houston, TX 77030 USA Kings Coll Hosp London, Dept Haematol Med, London, EnglandAzarnia, N.论文数: 0 引用数: 0 h-index: 0机构: Onconova Therapeut Inc, Biometr, Newtown, PA USA Kings Coll Hosp London, Dept Haematol Med, London, EnglandPetrone, M. E.论文数: 0 引用数: 0 h-index: 0机构: Onconova Therapeut Inc, Pharmacovigilance & Med & Sci Commun, Newtown, PA USA Kings Coll Hosp London, Dept Haematol Med, London, EnglandSnyder, B. R.论文数: 0 引用数: 0 h-index: 0机构: Onconova Therapeut Inc, Med & Sci Commun, Newtown, PA USA Kings Coll Hosp London, Dept Haematol Med, London, EnglandGohring, G.论文数: 0 引用数: 0 h-index: 0机构: Hannover Med Sch, Inst Human Genet, Hannover, Germany Kings Coll Hosp London, Dept Haematol Med, London, England
- [37] Computational Biology Approach to Predict Hypomethylating Agent (HMA) Response Using Genomic and Clinical Characteristics in Myelodsyplastic Syndromes (MDS)BLOOD, 2017, 130Drusbosky, Leylah M.论文数: 0 引用数: 0 h-index: 0Komrokji, Salah-Eddin论文数: 0 引用数: 0 h-index: 0Al Ali, Najla论文数: 0 引用数: 0 h-index: 0Singh, Neeraj Kumar论文数: 0 引用数: 0 h-index: 0Kumar, Chandan论文数: 0 引用数: 0 h-index: 0Vasista, Sumanth论文数: 0 引用数: 0 h-index: 0Sahu, Diwyanshu论文数: 0 引用数: 0 h-index: 0Naga, Ganesh论文数: 0 引用数: 0 h-index: 0Dattatraya, Patil论文数: 0 引用数: 0 h-index: 0Abbasi, Taher论文数: 0 引用数: 0 h-index: 0Vali, Shireen论文数: 0 引用数: 0 h-index: 0Sallman, David A.论文数: 0 引用数: 0 h-index: 0Komrokji, Rami S.论文数: 0 引用数: 0 h-index: 0Cogle, Christopher R.论文数: 0 引用数: 0 h-index: 0
- [38] Next-generation sequencing of 213 MDS patient samples identifies mutation profiles associated with response to hypomethylating agents and overall survivalLEUKEMIA RESEARCH, 2013, 37 : S19 - S20Bejar, R.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Diego, Hematol Oncol, San Diego, CA 92103 USA Univ Calif San Diego, Hematol Oncol, San Diego, CA 92103 USAStevenson, K.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Biostat & Computat Biol, Boston, MA 02115 USA Univ Calif San Diego, Hematol Oncol, San Diego, CA 92103 USAStojanov, P.论文数: 0 引用数: 0 h-index: 0机构: Broad Inst, Canc Genome Computat Anal, Boston, MA USA Univ Calif San Diego, Hematol Oncol, San Diego, CA 92103 USAZaneveld, J. E.论文数: 0 引用数: 0 h-index: 0机构: Baylor Univ, Mol & Human Genet, Houston, TX 77030 USA Univ Calif San Diego, Hematol Oncol, San Diego, CA 92103 USABar-Natan, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Diego, Hematol Oncol, San Diego, CA 92103 USACaughey, B.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA Univ Calif San Diego, Hematol Oncol, San Diego, CA 92103 USAWang, H.论文数: 0 引用数: 0 h-index: 0机构: Baylor Univ, Mol & Human Genet, Houston, TX 77030 USA Univ Calif San Diego, Hematol Oncol, San Diego, CA 92103 USAGarcia-Manero, G.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA Univ Calif San Diego, Hematol Oncol, San Diego, CA 92103 USAKantarjian, H.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA Univ Calif San Diego, Hematol Oncol, San Diego, CA 92103 USA论文数: 引用数: h-index:机构:Getz, G.论文数: 0 引用数: 0 h-index: 0机构: Broad Inst, Canc Genome Computat Anal, Boston, MA USA Univ Calif San Diego, Hematol Oncol, San Diego, CA 92103 USASteensma, D. P.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Med Oncol Leukemia, Boston, MA 02115 USA Univ Calif San Diego, Hematol Oncol, San Diego, CA 92103 USAStone, R. M.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Med Oncol Leukemia, Boston, MA 02115 USA Univ Calif San Diego, Hematol Oncol, San Diego, CA 92103 USAChen, R.论文数: 0 引用数: 0 h-index: 0机构: Baylor Univ, Mol & Human Genet, Houston, TX 77030 USA Univ Calif San Diego, Hematol Oncol, San Diego, CA 92103 USA论文数: 引用数: h-index:机构:Ebert, B. L.论文数: 0 引用数: 0 h-index: 0机构: Brigham & Womens Hosp, Hematol, Boston, MA 02115 USA Univ Calif San Diego, Hematol Oncol, San Diego, CA 92103 USA
- [39] IMPACT OF MARROW COMPLETE RESPONSE IN THE NATURAL HISTORY OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) AND CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) TREATED WITH HYPOMETHYLATING AGENTSHAEMATOLOGICA, 2017, 102 : 263 - 264Pierola, A. Alfonso论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USAMontalban-Bravo, G.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USATakahashi, K.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USAJabbour, E. J.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USAKadia, T.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USARavandi, F.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USACortes, J.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USADiNardo, C.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USADaver, N.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USABorthakur, G.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USAPemmaraju, N.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USAKonopleva, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USABueso-Ramos, C.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Hematopathol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USAPierce, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USAKantarjian, H.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USAGarcia-Manero, G.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA
- [40] Omacetaxine mepesuccinate for patients with higher-risk MDS and CMML after failure of hypomethylating agents: A phase II clinical trial.JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)Sanchez-Petitto, Gabriela论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr, Houston, TX USAGarcia-Manero, Guillermo论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr, Houston, TX USAShort, Nicholas James论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr, Houston, TX USANaqvi, Kiran论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr, Houston, TX USAAndreeff, Michael论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr, Houston, TX USATakahashi, Koichi论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr, Houston, TX USAKornblau, Steven论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr, Houston, TX USABose, Prithviraj论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr, Houston, TX USAEstrov, Zeev论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr, Houston, TX USAKonopleva, Marina论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr, Houston, TX USAPatel, Ami论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr, Houston, TX USAIslam, Rabiul论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr, Houston, TX USAAlvarado, Yesid论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr, Houston, TX USADinardo, Courtney Denton论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr, Houston, TX USAKantarjian, Hagop M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr, Houston, TX USAJabbour, Elias论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr, Houston, TX USA